vimarsana.com

Page 377 - குடியரசுக் கட்சியினர் இல் காங்கிரஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharmaceutical company AbbVie inflated prices for two major drugs, House Oversight report says

Pharmaceutical company AbbVie inflated prices for two major drugs, House Oversight report says Rebecca Shabad and Dareh Gregorian © Provided by NBC News WASHINGTON Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. who take the drugs Humira and Imbruvica, a report released Tuesday by the House Oversight and Reform Committee found. The committee concluded that the price increases led to billions of dollars in corporate revenue and hefty bonuses for company executives. “AbbVie pursued a variety of tactics to increase drug sales while raising prices for Americans, including exploiting the patent system to extend its market monopoly, abusing orphan drug protections to further block competition, and engaging in anticompetitive pricing practices,” the 43-page report states.

David Horowitz and the Principled Conservatives

When I read the May 5 New Republic article entitled “Our Friend, the Trump Propagandist,” by Ronald Radosh and Sol Stern, I thought of the novelist Martin Amis and the late critic Christopher Hitchens. They were best buddies, but on at least one occasion they reviewed each other’s work scathingly. In his 2002 book Koba the Dread, Amis excoriated Hitchens, a longtime self-styled Trotskyite, for soft-pedaling Stalin’s atrocities; in reply, Hitchens savaged Amis’s book in the Atlantic. You might expect that disagreement on such a topic would have led to an incurable rift; yet Amis and Hitchens remained close, and the former ended up delivering the eulogy at the latter’s funeral.

Voting rights legislation remains stalled in Congress

Updated: 10:25 AM EDT May 18, 2021 By Fredreka Schouten, CNN West Virginia Sen. Joe Manchin, a Democrat, and Alaska Sen. Lisa Murkowski, a Republican, issued a letter this week urging Congress to find a bipartisan path forward to reauthorize the decades-old Voting Rights Act.The missive to congressional leaders in the House and Senate seeks to break through the impasse on voting rights legislation as Republican-led states around the country erect new barriers to the ballot box. Since enactment, the Voting Rights Act of 1965 has been reauthorized and amended five times with large, bipartisan majorities, the senators wrote. Protecting Americans access to democracy has not been a partisan issue for the past 56 years, and we must not allow it to become one now. But partisan battles have dominated voting rights debates in Washington and in the states, and bipartisan compromise appears elusive on any of the federal voting bills.Here s a look at the competing election b

Build America Bond Revival Draws Bipartisan Support in Congress

May 19 2021, 3:46 AM May 18 2021, 10:01 PM May 19 2021, 3:46 AM (Bloomberg) Democrats and Republicans in Congress are in favor of reviving an Obama-era bond program for states and cities to help spur increased spending on infrastructure projects. (Bloomberg) Democrats and Republicans in Congress are in favor of reviving an Obama-era bond program for states and cities to help spur increased spending on infrastructure projects. Senator Ron Wyden, a Democrat from Oregon who chairs the Senate Finance committee, said at a hearing of the panel Tuesday that there is bipartisan support for creating a new borrowing program akin to Build America Bonds as President Joe Biden seeks to enact a major infrastructure spending plan. The federal government paid some of the interest bill for such securities under a temporary program enacted after the last recession.

Biden at odds with some Democrats over Israel - The Washington Post

Biden at odds with some Democrats over Israel - The Washington Post
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.